Ivana Bozic
Ivana Bozic
Assistant Professor of Applied Mathematics, University of Washington
Verified email at uw.edu - Homepage
Title
Cited by
Cited by
Year
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
S Yachida, S Jones, I Bozic, T Antal, R Leary, B Fu, M Kamiyama, ...
Nature 467 (7319), 1114-1117, 2010
22092010
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
LA Diaz Jr, RT Williams, J Wu, I Kinde, JR Hecht, J Berlin, B Allen, I Bozic, ...
Nature 486 (7404), 537-540, 2012
15132012
Accumulation of driver and passenger mutations during tumor progression
I Bozic, T Antal, H Ohtsuki, H Carter, D Kim, S Chen, R Karchin, ...
Proceedings of the National Academy of Sciences 107 (43), 18545-18550, 2010
7172010
Mutations driving CLL and their evolution in progression and relapse
DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ...
Nature 526 (7574), 525-530, 2015
6322015
Evolutionary dynamics of cancer in response to targeted combination therapy
I Bozic, JG Reiter, B Allen, T Antal, K Chatterjee, P Shah, YS Moon, ...
elife 2, e00747, 2013
4912013
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
B Waclaw, I Bozic, ME Pittman, RH Hruban, B Vogelstein, MA Nowak
Nature 525 (7568), 261-264, 2015
3562015
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
JA Burger, DA Landau, A Taylor-Weiner, I Bozic, H Zhang, K Sarosiek, ...
Nature communications 7 (1), 1-13, 2016
2122016
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
AP Makohon-Moore, M Zhang, JG Reiter, I Bozic, B Allen, D Kundu, ...
Nature genetics 49 (3), 358-366, 2017
2002017
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
S Misale, I Bozic, J Tong, A Peraza-Penton, A Lallo, F Baldi, KH Lin, ...
Nature communications 6 (1), 1-9, 2015
922015
Quantifying clonal and subclonal passenger mutations in cancer evolution
I Bozic, JM Gerold, MA Nowak
PLoS computational biology 12 (2), e1004731, 2016
912016
Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers
I Bozic, MA Nowak
Proceedings of the National Academy of Sciences 111 (45), 15964-15968, 2014
902014
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
DA Landau, C Sun, D Rosebrock, SEM Herman, J Fein, M Sivina, ...
Nature communications 8 (1), 1-12, 2017
772017
Reconstructing metastatic seeding patterns of human cancers
JG Reiter, AP Makohon-Moore, JM Gerold, I Bozic, K Chatterjee, ...
Nature communications 8 (1), 1-10, 2017
742017
Dynamics of targeted cancer therapy
I Bozic, B Allen, MA Nowak
Trends in molecular medicine 18 (6), 311-316, 2012
712012
Prediction of supertype-specific HLA class I binding peptides using support vector machines
GL Zhang, I Bozic, CK Kwoh, JT August, V Brusic
Journal of immunological methods 320 (1-2), 143-154, 2007
432007
Dormant tumour cells, their niches and the influence of immunity
ET Goddard, I Bozic, SR Riddell, CM Ghajar
Nature cell biology 20 (11), 1240-1249, 2018
382018
Zero-divisor graphs of matrices over commutative rings
I Božić, Z Petrović
Communications in Algebra 37 (4), 1186-1192, 2009
382009
Resisting resistance
I Bozic, MA Nowak
Annual Reviews, 2017
352017
The effect of one additional driver mutation on tumor progression
JG Reiter, I Bozic, B Allen, K Chatterjee, MA Nowak
Evolutionary Applications 6 (1), 34-45, 2013
352013
Unwanted evolution
I Bozic, MA Nowak
science 342 (6161), 938-939, 2013
252013
The system can't perform the operation now. Try again later.
Articles 1–20